Results
93
Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.
93 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
KEBNI B | SEK 1.21 | -5.9% | -1.8% | SEK 329.2m | SEK 2.20 | PS2.9x | E86.1% | n/a | Tech | ||
YUBICO | SEK 250.00 | -6.4% | 150.8% | SEK 21.5b | SEK 321.67 | PE111.1x | E42.3% | n/a | Software | ||
CTT | SEK 275.00 | -0.7% | 21.1% | SEK 3.4b | n/a | PE33.8x | E24.8% | 1.9% | Capital Goods | ||
TRUE B | SEK 36.90 | 6.8% | 1.5% | SEK 12.7b | SEK 57.20 | PE26.6x | E21.6% | 1.1% | Software | ||
MAGLE | SEK 37.60 | -2.6% | 18.2% | SEK 406.1m | SEK 50.00 | PE52.8x | E72.2% | n/a | Pharmaceuticals & Biotech | ||
FNOX | SEK 59.72 | -0.3% | 7.9% | SEK 36.4b | SEK 77.88 | PE56x | E22.6% | 0.3% | Software | ||
BIOA B | SEK 168.00 | -2.4% | -46.4% | SEK 14.8b | SEK 290.60 | PS49.6x | E98.4% | 0% | Pharmaceuticals & Biotech | ||
BIOVIC B | SEK 2.52 | -3.3% | -65.7% | SEK 211.4m | SEK 7.90 | PS29x | E73.1% | n/a | Pharmaceuticals & Biotech | ||
INCOAX | SEK 2.26 | -1.7% | -4.6% | SEK 244.4m | SEK 2.84 | PS2.3x | E115.5% | n/a | Tech | ||
CRAD B | SEK 40.05 | -3.3% | 34.8% | SEK 1.3b | SEK 57.00 | PE25.1x | E33.9% | n/a | Healthcare | ||
ORGC | SEK 3.06 | -7.3% | -15.0% | SEK 300.2m | SEK 3.00 | PS2.2x | E109.0% | n/a | Materials | ||
ESGR B | SEK 26.95 | -9.0% | -51.9% | SEK 177.5m | SEK 58.00 | PB0.9x | E56.6% | n/a | Household | ||
FLEXQ | SEK 9.60 | -6.8% | -45.5% | SEK 128.7m | SEK 25.00 | PS1.2x | E118.7% | n/a | Capital Goods | ||
CTM | SEK 7.21 | -0.7% | -63.4% | SEK 545.4m | SEK 29.70 | PB0.3x | E123.9% | 0% | Media | ||
KLAR | SEK 0.80 | 78.1% | 35.7% | SEK 103.5m | SEK 1.00 | PB5x | E57.8% | n/a | Pharmaceuticals & Biotech | ||
4C | SEK 16.50 | 8.6% | -29.2% | SEK 579.7m | SEK 22.00 | PS2x | E108.0% | n/a | Software | ||
SENZA | SEK 7.30 | -2.7% | -10.1% | SEK 215.4m | SEK 16.00 | PS3.9x | E109.9% | n/a | Pharmaceuticals & Biotech | ||
EQT | SEK 324.20 | 2.0% | 48.7% | SEK 383.0b | SEK 354.83 | PE111.2x | E35.9% | 1.1% | Diversified Financials | ||
EGTX | SEK 5.32 | -6.5% | 25.3% | SEK 1.6b | SEK 11.40 | PS22x | E90.0% | n/a | Pharmaceuticals & Biotech | ||
RUSTA | SEK 68.95 | 0.3% | n/a | SEK 10.4b | SEK 86.00 | PE25.6x | E22.2% | 1.7% | Retail | ||
ALELIO | SEK 0.05 | 0.6% | -91.2% | SEK 31.1m | n/a | PE-0.5x | E106.6% | n/a | Capital Goods | ||
TENEO | SEK 0.44 | -7.2% | -58.3% | SEK 164.2m | n/a | PS1.8x | E66.8% | n/a | Software | ||
LIME | SEK 307.00 | -1.4% | 17.4% | SEK 4.1b | SEK 353.33 | PE47.4x | E24.1% | 1.1% | Software | ||
RAIL | SEK 30.70 | 2.3% | 71.0% | SEK 740.6m | SEK 34.00 | PE16.9x | E27.0% | 2.3% | Transportation |